Top Markets
Coin of the day
Glenmark Life Sciences Limited Glenmark Life Sciences Limited

Glenmark Life Sciences Limited

GLS
株式のランク #7700
Glenmark Life Sciences Limited, an Indian entity established in Mumbai in 2011,... Glenmark Life Sciences Limited, an Indian entity established in Mumbai in 2011, specializes in the creation, manufacturing, and distribution of high-value active pharmaceutical ingredients (APIs). These APIs are utilized across a wide array of chronic therapeutic areas. The company's diverse portfolio includes compounds for managing cardiovascular diseases (e.g., Olmesartan, Rosuvastatin, Amiodarone), central nervous system conditions (such as Oxcarbazepine, Topiramate, Lacosamide), and diabetes (including Glimepiride, Teneligliptin, Linagliptin). Additionally, they produce APIs for pain management (Etoricoxib, Lornoxicam), gastro-intestinal disorders, anti-infective treatments, respiratory ailments, and anti-emetic applications, featuring products like Atovaquone, Fluconazole, and Esomeprazole Magnesium. Beyond API production, Glenmark Life Sciences offers contract development and manufacturing (CDMO) solutions to numerous multinational and specialty pharmaceutical firms. Operating as a subsidiary of Glenmark Pharmaceuticals Limited, the company exports its products worldwide, reaching markets in Europe, North America, Latin America, and Japan.
株価
$12.18
最終同期: 2025-02-17
時価総額
$1.49B
変化(1日)
4.21%
変化(1年)
0.00%
IN
取引 Glenmark Life Sciences Limited (GLS)

カテゴリー

Glenmark Life Sciences Limited(GLS)の株価履歴
終値の最高値: $13.07 (2025-02-01)

終値の最安値: $9.63 (2021-08-01)
Glenmark Life Sciences Limited の株価履歴(2021 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2025 8.46%
2024 56.27%
2023 49.21%
2022 -36.04%
2021 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$171.67 -
DE
$166.00 32.21%
DE
$37.84 25.57%
JP
$223.37 28.13%
CH
$21.19 17.04%
IN